Latest long-term debt for MTP: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2025), MTP shows a long-term debt of $0. That compares with $120K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MTP's long-term debt is now $0 (was $120K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Midatech Pharma Plc is outperforming or lagging.
Tracking MTP's long-term debt over time shows whether Midatech Pharma Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $120K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Midatech Pharma Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.
Midatech Pharma Plc's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.